Ultra-long-acting insulin degludec has consistently lower pharmacodynamic variability than insulin glargine over 24 h at steady state
- Autori: Buscemi, S; Heise, T; Hermanski, L; Nosek, L; Feldmann, A; Rasmussen, S; Nicoziani, P; Haahr, S
- Anno di pubblicazione: 2012
- Tipologia: Abstract in rivista (Abstract in rivista)
- Parole Chiave: diabetes, insulin degludec, pharmacodynamic variability
- OA Link: http://hdl.handle.net/10447/79630